Abstract
Plasma and erythrocyte lipid peroxidation levels of 20 patients with histopathologically confirmed testis cancer and 20 healthy control individuals were studied between November 1995 and June 1997. The group with testis cancer had a mean age of 24.8±8.2 yr and the control group’s mean age was 28.3±6.9 yr. Stage distribution of the testis cancer cases were 4 of stage A, 10 of stage B, and 6 of stage C. Blood samples of the patients were drawn after orchiectomy and after 12 h fasting before chemotherapy. Mean plasma and erythrocyte lipid peroxidation levels were detected to be 14.51±5.30 nmol malondialdehide (MDA)/mL and 9.30±2.06 nmol MDA/g hemoglobin (Hb), respectively, in the testis cancer group, whereas the healthy control group had mean plasma and erythrocyte lipid peroxidation levels of 10.7±1.82 nmol MDA/mL and 6.18±1.68 nmol MDA/g Hb, respectively. Plasma and erythrocyte lipid peroxidation values of the testis cancer patients were determined to be statistically significantly higher than that of the health control group (p<0.001, p<0.001). No significant correlation was determined between plasma, erythrocyte lipid peroxidation levels and tumor markers. In conclusion, it can be said that an increase in the lipid peroxidation may play a role in the pathogenesis of testis carcinomas in addition to the other causes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. Miyake and S. Fuchimato, Production of hydroxyl radicals by tumor cells measured by electron spin resonance spectrometry. Res. Commun. Chem. Pathol. Pharmacol. 71(3), 293–307 (1990).
K. Yagi, Lipid pereoxides and related radicals in clinical medicine. Bioassays 1, 58–60 (1984).
P. A. Cerutti, Prooxidant state and tumor promotion. Science 227, 375–382 (1985).
K. H. Cheesman, Mechanism and effects of lipid peroxidation. Mol. Aspects Med. 14, 191–197 (1993).
K. H. Cheesman and T. F. Slatter, An introduction to free radical biochemistry. Br. Med. Bull. 49, 481–493 (1993).
M. U. Dianzani, Lipid peroxidation and cancer. Crit. Rev. Oncol. Hemat. 15, 125–147 (1993).
E. N. Frankel, Lipid oxidation: mechanism, products and biological significance. JAOCS 61, 1909–1916 (1984).
R. E. Pacifici and K. J. Davies, Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37, 166–180 (1991).
T. L. Dormady, An approach to free radicals. Lancet 2, 1010–1014 (1983).
C. W. Hendrickse, R. W. Kelly, and S. Radley, Lipid peroxidation and prostoglandins in colorectal cancer. Br. J. Surgery 81, 1219–1223 (1994).
T. Zima, I. Spickal, and S. Stipek, Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma. Neoplasma 43(2), 69–73 (1996).
L. N. Vernie, C. Zegers, and C. S. Baldew, Cisplatin induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients. Cancer Lett. 40, 83–91 (1988).
T. Koizumi and Z. G. Li, Role of oxidative stress in single-dose, cadmium induced testicular cancer. J. Toxicol. Environ. Health 37(1), 25–36 (1992).
N. Sugawara and C. Sugawara, Selenium protection against testicular lipid peroxidation from cadmium. J. Appl. Biochem. 6, 199–204 (1984).
J. P. Richie, Advances in the diagnosis and treatment of testicular cancer. Cancer Invest. 11(6), 670–675 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Öztürk, B., Güven, M., Arpaci, F. et al. Plasma and erythrocyte lipid peroxidation levels in patients with testis tumor after orchiectomy. Biol Trace Elem Res 73, 181–187 (2000). https://doi.org/10.1385/BTER:73:2:181
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:73:2:181